<?xml version="1.0" encoding="UTF-8"?>
<ref id="B97-antibiotics-10-00092">
 <label>97.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Jeon</surname>
    <given-names>Y.T.</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Qiao</surname>
    <given-names>J.X.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Ruel</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Thibeault</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Hiebert</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>T.C.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>Y.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Identification of 1-{2-[4-chloro-1′-(2,2-dimethylpropyl)-7-hydroxy-1,2-dihydrospiro[indole-3,4′-piperidine]-1-yl]phenyl}-3-{5-chloro-[1,3]thiazolo [5,4-b]pyridin-2-yl}urea, a potent, efficacious and orally bioavailable P2Y
   <sub>1</sub> antagonist as an antiplatelet agent
  </article-title>
  <source>Bioorg. Med. Chem. Lett.</source>
  <year>2014</year>
  <volume>24</volume>
  <fpage>1294</fpage>
  <lpage>1298</lpage>
  <?supplied-pmid 24513044?>
  <pub-id pub-id-type="pmid">24513044</pub-id>
 </element-citation>
</ref>
